Intellectual Property Contracts & Agreements

18,787 Contracts & Agreements
Intellectual property agreements include contracts relating to copyrights, trademarks, patents, and other inventions.
Browse by Subcategory Browse by Industry
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Exclusive License Agreement, by and between the Company and MIRALOGX LLC dated June 3, 2026
License Agreements
MIRA PHARMACEUTICALS, INC.
Pharmaceuticals
2026
Technology License and Distribution Agreement between Manako Labs Ltd and TaoWeave, Inc.
License Agreements
GLOWPOINT, INC.
Software
2026
First Amendment to Intellectual Property License Agreement between BP United, Inc. and Quantum Cyber N.V. (June 2026)
License Agreements
MAINZ BIOMED N.V.
2026
First Amendment to IL-23 License Agreement between Paragon Therapeutics, Inc. and Oruka Therapeutics, Inc. dated May 29, 2026
License Agreements
ARCA biopharma, Inc.
Biotechnology
2026
Trademark License Agreement between Federal Express Corporation and FDXF Holding Corporation (May 31, 2026)
Trademark Agreements
FedEx Freight Holding Company, Inc.
2026
First Amendment to Amended and Restated License Agreement between Paragon Therapeutics, Inc. and Spyre Therapeutics, Inc.
License Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
2026
Trademark License Agreement between Federal Express Corporation and FDXF Holding Corporation (May 31, 2026)
Trademark Agreements
FedEx
Air Freight & Logistics
2026
Intellectual Property Cross-License Agreement among FedEx Corporation, Federal Express Corporation, FedEx Dataworks, Inc., and FDXF Holding Corporation (May 31, 2026)
License Agreements
FedEx Freight Holding Company, Inc.
2026
Intellectual Property Cross-License Agreement among FedEx Corporation, Federal Express Corporation, FedEx Dataworks, Inc., and FDXF Holding Corporation (May 31, 2026)
License Agreements
FedEx
Air Freight & Logistics
2026
Strategic Technology License Agreement, dated as of May 27, 2026, by and among FOXO Technologies Inc., FOXO Labs, Inc., Jon R. Sabes, and LongevityFP Technologies, LLC (Certain...
License Agreements
Delwinds Insurance Acquisition Corp.
SPACs, Investment, & Acquisition Companies
2026
Amendment No. 1 to Exclusive License Agreement, by and between the Company and MIRALOGX, dated as of May 21, 2026
License Agreements
MIRA PHARMACEUTICALS, INC.
Pharmaceuticals
2026
License and Collaboration Agreement between Parabilis Medicines, Inc. and Regeneron Pharmaceuticals, Inc. dated May 15, 2026
License Agreements
Parabilis Medicines, Inc.
2026
Patent License and Know-How Agreement between Mayo Foundation for Medical Education and Research and Rancho Santa Fe Bio, Inc.
License Agreements
Kardigan, Inc.
2026
License Agreement between Sanofi and Rancho Santa Fe Bio, Inc. dated June 2, 2021
License Agreements
Kardigan, Inc.
2026
License Agreement between Ionis Pharmaceuticals, Inc. and EnCarda, Inc. Effective June 7, 2024
License Agreements
Kardigan, Inc.
2026
License Agreement between EnCarda, Inc. and Bristol-Myers Squibb Company Dated November 4, 2024
License Agreements
Kardigan, Inc.
2026
License Agreement between EnCarda, Inc. and MyoKardia, Inc. Dated November 4, 2024
License Agreements
Kardigan, Inc.
2026
Exclusive License Agreement between Rocket One Inc. and Virginia Commonwealth University Intellectual Property Foundation (May 15, 2026)
License Agreements
Hoth Therapeutics, Inc.
Pharmaceuticals
2026
Exclusive License Agreement between Rocket One Inc. and Virginia Commonwealth University Intellectual Property Foundation (May 15, 2026)
License Agreements
Hoth Therapeutics, Inc.
Pharmaceuticals
2026
License Agreement between FOG Pharmaceuticals, Inc. and President and Fellows of Harvard College (August 30, 2017)
License Agreements
Parabilis Medicines, Inc.
2026
Intellectual Property License Agreement between BP United, Inc. and Quantum Cyber N.V. dated May 12, 2026
License Agreements
MAINZ BIOMED N.V.
2026
First Amendment to License Agreement between BioAtla, Inc. and Context Therapeutics Inc. (May 14, 2026)
License Agreements
Context Therapeutics Inc.
Pharmaceuticals
2026
First Amendment to License Agreement between BioAtla, Inc. and Context Therapeutics Inc.
License Agreements
BioAtla, Inc.
Biotechnology
2026
Amendment No. 1 to License Agreement between AnaptysBio, Inc. and Centessa Pharmaceuticals (UK) Limited
License Agreements
First Tracks Biotherapeutics, Inc.
2026
License Agreement between AnaptysBio, Inc. and Centessa Pharmaceuticals (UK) Limited Dated November 24, 2023
License Agreements
First Tracks Biotherapeutics, Inc.
2026
Amendment No. 3 to Cell Line License Agreement between WuXi Biologics (Hong Kong) Limited and Invivyd, Inc.
License Agreements
Adagio Therapeutics, Inc.
Biotechnology
2026
Exclusive License Agreement between Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, and Eton Pharmaceuticals, Inc. (February 27, 2026)
License Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2026
Third Amendment to Rider to License Agreement Vivarium between MIL 40G, LLC and Cue Biopharma, Inc.
License Agreements
Cue Biopharma, Inc.
Biotechnology
2026
Exclusive License Agreement between Emory University and REGENXBIO Inc. (LIC.18.023)
License Agreements
REGENXBIO Inc.
Biotechnology
2026
Amendment No. 3 to License Agreement between Xencor, Inc. and Zenas BioPharma, Inc.
License Agreements
Zenas BioPharma, Inc.
Pharmaceuticals
2026
First Amendment to License Agreement for Use of Catalent IPSC Lines Between Catalent Düsseldorf GmbH and Clade Therapeutics, Inc.
License Agreements
Century Therapeutics, Inc.
Biotechnology
2026
Amended and Restated License Agreement between SEKISUI HOUSE, LTD. and Sekisui House U.S., Inc. (April 30, 2026)
License Agreements
M.D.C. Holdings, Inc.
Household Durables
2026
Amendment No. 3 to License Agreement between Immunome, Inc. and Bristol-Myers Squibb Company
License Agreements
Immunome Inc.
Biotechnology
2026
Exclusive License Agreement Between Impetis Biosciences Limited and Vyome Holdings, Inc. (March 15, 2026)
License Agreements
OBALON THERAPEUTICS INC
Health Care Equipment & Supplies
2026
Amendment No. 6 to Collaboration and Exclusive License Agreement between AnaptysBio, Inc. and TESARO, Inc.
License Agreements
ANAPTYSBIO INC
Biotechnology
2026
Second Amendment to License Agreement between Aura Biosciences, Inc. and Clearside Royalty LLC
License Agreements
Aura Biosciences, Inc.
Biotechnology
2026
Patent License Agreement between Avenue Therapeutics, Inc. and Duke University (Effective February 18, 2026)
License Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2026
Intellectual Property Assignment and Grant-Back Agreement between Oncotelic Therapeutics, Inc. and NeuroBridge IP Holdings Incorporated
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
2026
Amended and Restated Material Transfer and License Agreement among Anthony Nolan, INMUNE BIO International Ltd, and INMUNE BIO Inc. dated April 29, 2026
License Agreements
Inmune Bio, Inc.
Biotechnology
2026
Amendment No. 1 to Master License Agreement between Schrdinger, Inc. and The Trustees of Columbia University
License Agreements
Schrodinger, Inc.
Health Care Technology
2026